Rikard, R. A., Chargualaf, L. M., Coulter, C., Weimer, E. T., Schmitz, J. L., Kotzen, E. S., . . . Szempruch, K. R. (2024). Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen. Wiley. https://doi.org/10.1111/ctr.15244
Cita Chicago Style (17a ed.)Rikard, Rachel A., Laura M. Chargualaf, Carolyn Coulter, Eric T. Weimer, John L. Schmitz, Elizabeth S. Kotzen, Alyson Prom, Alexander H. Toledo, y Kristen R. Szempruch. Alemtuzumab Versus Anti‐thymocyte Globulin in Kidney Transplant Recipients Receiving a Rapid Steroid Withdrawal Regimen. Wiley, 2024. https://doi.org/10.1111/ctr.15244.
Cita MLA (9a ed.)Rikard, Rachel A., et al. Alemtuzumab Versus Anti‐thymocyte Globulin in Kidney Transplant Recipients Receiving a Rapid Steroid Withdrawal Regimen. Wiley, 2024. https://doi.org/10.1111/ctr.15244.